Low levels of HIV-1 drug resistance mutations in patients who achieved viral re-suppression without regimen switch: a retrospective study

por Onwuamah, Chika K., Okpokwu, Jonathan, Audu, Rosemary, Imade, Godwin, Meloni, Seema T., Okwuraiwe, Azuka, Chebu, Philippe, Musa, Adesola Z., Chaplin, Beth, Dalhatu, Ibrahim, Agbaji, Oche, Samuels, Jay, Ezechi, Oliver, Ahmed, Mukhtar, Odaibo, Georgina, Olaleye, David O., Okonkwo, Prosper, Salako, Babatunde Lawal, Raizes, Elliot, Yang, Chunfu, Kanki, Phyllis J., Idigbe, Emmanuel O.
Publicado 2020

Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options

por Meloni, Seema T, Onwuamah, Chika K, Agbaji, Oche, Chaplin, Beth, Olaleye, David O, Audu, Rosemary, Samuels, Jay, Ezechi, Oliver, Imade, Godwin, Musa, Adesola Z, Odaibo, Georgina, Okpokwu, Jonathan, Rawizza, Holly, Mu’azu, Muhammad A, Dalhatu, Ibrahim, Ahmed, Mukhtar, Okonkwo, Prosper, Raizes, Elliot, Ujah, Innocent A O, Yang, Chunfu, Idigbe, Emmanuel O, Kanki, Phyllis J
Publicado 2017